G, D., S, H., S, M., H, A., AMN, K., H, T., . . . SL, B. (2024). Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK. ERJ open research, 10(1), . https://doi.org/10.1183/23120541.00529-2023
Chicago Style (17th ed.) CitationG, Dixon, et al. "Real-world Experience of Nintedanib for Progressive Fibrosing Interstitial Lung Disease in the UK." ERJ Open Research 10, no. 1 (2024). https://doi.org/10.1183/23120541.00529-2023.
MLA (9th ed.) CitationG, Dixon, et al. "Real-world Experience of Nintedanib for Progressive Fibrosing Interstitial Lung Disease in the UK." ERJ Open Research, vol. 10, no. 1, 2024, https://doi.org/10.1183/23120541.00529-2023.
Warning: These citations may not always be 100% accurate.